title: The estimated impact of human papillomavirus vaccine coverage on the lifetime cervical cancer burden among girls currently aged 12 years and younger in the United States.
abstract: Using a previously published dynamic model, we illustrate the potential benefits of human papillomavirus vaccination among girls currently 12 years or younger in the United States. Increasing vaccine coverage of young girls to 80% would avert 53,300 lifetime cervical cancer cases versus 30% coverage and 28,800 cases versus 50% coverage.
authors.affiliation: From the *Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA; and †Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
authors.forename: Harrell W
authors.initials: HW
authors.lastname: Chesson
authors.forename: Donatus U
authors.initials: DU
authors.lastname: Ekwueme
authors.forename: Mona
authors.initials: M
authors.lastname: Saraiya
authors.forename: Eileen F
authors.initials: EF
authors.lastname: Dunne
authors.forename: Lauri E
authors.initials: LE
authors.lastname: Markowitz
mesh_terms: D000293:Adolescent; D002648:Child; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D005260:Female; D019538:Health Care Surveys; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D017589:Immunization Programs / Q000191:economics / Q000458:organization & administration; D032541:Mass Vaccination / Q000191:economics; D018803:Models, Economic; D030361:Papillomavirus Infections / Q000191:economics / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000191:economics / Q000276:immunology; D010342:Patient Acceptance of Health Care; D015995:Prevalence; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000191:economics / Q000517:prevention & control*
chemical_list: D053918:Papillomavirus Vaccines